UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Drug Pricing Stewardship from Mark Cuban’s Cost Plus Generic Drug Program

PharmacoEconomics, 2024-11, Vol.42 (11), p.1279-1286

2024

Volltextzugriff (PDF)

Effectiveness and safety of generic tofacitinib in alopecia areata: is the generic a cost-effective option? A retrospective study

Archives of dermatological research, 2024-05, Vol.316 (5), p.154-154, Article 154

2024

Volltextzugriff (PDF)

Biosimilars: How Can Payers Get Long-Term Savings?

PharmacoEconomics, 2016-06, Vol.34 (6), p.609-616

2016

Volltextzugriff (PDF)

Variations in Patients' Perceptions and Use of Generic Drugs: Results of a National Survey

Journal of general internal medicine : JGIM, 2016-06, Vol.31 (6), p.609-614

2016

Volltextzugriff (PDF)

Evaluation of the Generic Drug User Fee Act (GDUFA) Program for Fiscal Years 2013–2022

The AAPS journal, 2024-07, Vol.26 (5), p.85, Article 85

2024

Volltextzugriff (PDF)

Availability, price, and affordability of anti-hepatitis B virus drugs: a cross-sectional study in China

International journal of clinical pharmacy, 2024-06, Vol.46 (3), p.694-703

2024

Volltextzugriff (PDF)

Biosimilars of Biological Drug Therapies: Regulatory, Clinical and Commercial Considerations

Drugs (New York, N.Y.), 2011-08, Vol.71 (12), p.1527-1536

2011

Volltextzugriff (PDF)

Reasons for allowing and refusing generic substitution and factors determining the choice of an interchangeable prescription medicine: a survey among pharmacy customers in Finland

BMC health services research, 2020-02, Vol.20 (1), p.82-82, Article 82

2020

Volltextzugriff (PDF)

Cost Effectiveness of Atorvastatin in Patients with Type 2 Diabetes Mellitus: A Pharmacoeconomic Analysis of the Collaborative Atorvastatin Diabetes Study in the Belgian Population

Clinical drug investigation, 2010-01, Vol.30 (2), p.133-142

2010

Volltextzugriff (PDF)

The Impact of Patent Expiry on Drug Prices: A Systematic Literature Review

Applied health economics and health policy, 2018-10, Vol.16 (5), p.653-660

2018

Volltextzugriff (PDF)

The relationship between the number of available therapeutic options and government payer (medicare part D) spending on topical drug products

Archives of Dermatological Research, 2020-10, Vol.312 (8), p.559-565

2020

Volltextzugriff (PDF)

Availability, prices and affordability of selected essential medicines in Jordan: a national survey

BMC health services research, 2018-10, Vol.18 (1), p.787-787, Article 787

2018

Volltextzugriff (PDF)

Measuring and Understanding Market Exclusivity Length for New Prescription Drugs in France, Australia, and the USA

Pharmaceutical medicine, 2024-07, Vol.38 (4), p.303-310

2024

Volltextzugriff (PDF)

Relationship between pharmaceutical pricing strategies with price, availability, and affordability of cardiovascular disease medicines: surveys in Qatar and Lebanon

BMC health services research, 2019-12, Vol.19 (1), p.973-973, Article 973

2019

Volltextzugriff (PDF)

A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study

BMC pharmacology & toxicology, 2013-01, Vol.14 (1), p.1-1, Article 1

2013

Volltextzugriff (PDF)

A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries

Journal of the International AIDS Society, 2010-09, Vol.13 (1), p.35-35

2010

Volltextzugriff (PDF)

Did Generic Clopidogrel Commercialization Affect Trends of ER Consultations and Hospitalizations in the Population Treated with Clopidogrel?

Drugs & aging, 2019-08, Vol.36 (8), p.759-768

2019

Volltextzugriff (PDF)

A comparison of generic drug prices in seven European countries: a methodological analysis

BMC health services research, 2017-03, Vol.17 (1), p.242-242, Article 242

2017

Volltextzugriff (PDF)

Changing the cost of care for chronic myeloid leukemia: the availability of generic imatinib in the USA and the EU

Annals of hematology, 2015-04, Vol.94 (Suppl 2), p.249-257

2015

Volltextzugriff (PDF)

Development of multi-criteria decision analysis (MCDA) framework for off-patent pharmaceuticals - an application on improving tender decision making in Indonesia

BMC health services research, 2018-12, Vol.18 (1), p.1003-1003, Article 1003

2018

Volltextzugriff (PDF)

Strategies to Reduce Out-of-Pocket Medication Costs for Canadians Living with Heart Failure

Cardiovascular drugs and therapy, 2021-10, Vol.35 (5), p.1009-1023

2021

Volltextzugriff (PDF)

A Systematic Review of Physicians’ and Pharmacists’ Perspectives on Generic Drug Use: What are the Global Challenges?

Applied health economics and health policy, 2015-08, Vol.13 (Suppl 1), p.35-45

2015

Volltextzugriff (PDF)

Addressing the Regulatory and Scientific Challenges with Generic Orally Inhaled Drug Products

Pharmaceutical medicine, 2020-04, Vol.34 (2), p.93-102

2020

Volltextzugriff (PDF)

Can income-based co-payment rates improve disparity? The case of the choice between brand-name and generic drugs

BMC health services research, 2019-11, Vol.19 (1), p.780-780, Article 780

2019

Volltextzugriff (PDF)

The Diversity of Biosimilar Design and Development: Implications for Policies and Stakeholders

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2015-12, Vol.29 (6), p.365-372

2015

Volltextzugriff (PDF)

1 – 25 von 522

Suche als RSS-Feed

Aktive Filter

KollektionSpringer Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(470)
Mit Volltextzugriff
(498)

Publikationsform

Artikel
(522)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(383)
Life Sciences & Biomedicine
(376)
Generic Drugs
(352)
Humans
(343)
Medicine
(245)
Health Care Sciences & Services
(237)
Drugs, Generic - Economics
(210)
Medicine & Public Health
(210)
Public Health
(202)
Social Sciences
(193)
Economics
(190)
Business & Economics
(181)
Pharmaceutical Industry
(178)
Health Policy & Services
(168)
Health Economics
(166)
Drugs
(145)
Pharmacoeconomics And Health Outcomes
(136)
Prescription Drugs
(134)
Chemicals, Rubber, Drugs, Biotechnology, Plastics
(107)
Pharmaceuticals
(106)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Drug Pricing Stewardship from Mark Cuban’s Cost Plus Generic Drug Program

Effectiveness and safety of generic tofacitinib in alopecia areata: is the generic a cost-effective option? A retrospective study

Biosimilars: How Can Payers Get Long-Term Savings?

Variations in Patients' Perceptions and Use of Generic Drugs: Results of a National Survey

Evaluation of the Generic Drug User Fee Act (GDUFA) Program for Fiscal Years 2013–2022

Availability, price, and affordability of anti-hepatitis B virus drugs: a cross-sectional study in China

Biosimilars of Biological Drug Therapies: Regulatory, Clinical and Commercial Considerations

Reasons for allowing and refusing generic substitution and factors determining the choice of an interchangeable prescription medicine: a survey among pharmacy customers in Finland

Cost Effectiveness of Atorvastatin in Patients with Type 2 Diabetes Mellitus: A Pharmacoeconomic Analysis of the Collaborative Atorvastatin Diabetes Study in the Belgian Population

The Impact of Patent Expiry on Drug Prices: A Systematic Literature Review

The relationship between the number of available therapeutic options and government payer (medicare part D) spending on topical drug products

Availability, prices and affordability of selected essential medicines in Jordan: a national survey

Measuring and Understanding Market Exclusivity Length for New Prescription Drugs in France, Australia, and the USA

Relationship between pharmaceutical pricing strategies with price, availability, and affordability of cardiovascular disease medicines: surveys in Qatar and Lebanon

A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study

A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries

Did Generic Clopidogrel Commercialization Affect Trends of ER Consultations and Hospitalizations in the Population Treated with Clopidogrel?

A comparison of generic drug prices in seven European countries: a methodological analysis

Changing the cost of care for chronic myeloid leukemia: the availability of generic imatinib in the USA and the EU

Development of multi-criteria decision analysis (MCDA) framework for off-patent pharmaceuticals - an application on improving tender decision making in Indonesia

Strategies to Reduce Out-of-Pocket Medication Costs for Canadians Living with Heart Failure

A Systematic Review of Physicians’ and Pharmacists’ Perspectives on Generic Drug Use: What are the Global Challenges?

Addressing the Regulatory and Scientific Challenges with Generic Orally Inhaled Drug Products

Can income-based co-payment rates improve disparity? The case of the choice between brand-name and generic drugs

The Diversity of Biosimilar Design and Development: Implications for Policies and Stakeholders

Aktive Filter

Suchergebnisse filtern